201 related articles for article (PubMed ID: 26917736)
1. Inherited DDX41 mutations: 11 genes and counting.
Tawana K; Fitzgibbon J
Blood; 2016 Feb; 127(8):960-1. PubMed ID: 26917736
[No Abstract] [Full Text] [Related]
2. Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia.
Li R; Sobreira N; Witmer PD; Pratz KW; Braunstein EM
Haematologica; 2016 Jun; 101(6):e228-31. PubMed ID: 26944477
[No Abstract] [Full Text] [Related]
3. Myeloid neoplasms with germline DDX41 mutation.
Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
[TBL] [Abstract][Full Text] [Related]
4. DDX41-related myeloid neoplasia.
Maciejewski JP; Padgett RA; Brown AL; Müller-Tidow C
Semin Hematol; 2017 Apr; 54(2):94-97. PubMed ID: 28637623
[TBL] [Abstract][Full Text] [Related]
5. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
Lewinsohn M; Brown AL; Weinel LM; Phung C; Rafidi G; Lee MK; Schreiber AW; Feng J; Babic M; Chong CE; Lee Y; Yong A; Suthers GK; Poplawski N; Altree M; Phillips K; Jaensch L; Fine M; D'Andrea RJ; Lewis ID; Medeiros BC; Pollyea DA; King MC; Walsh T; Keel S; Shimamura A; Godley LA; Hahn CN; Churpek JE; Scott HS
Blood; 2016 Feb; 127(8):1017-23. PubMed ID: 26712909
[TBL] [Abstract][Full Text] [Related]
6. DDX41: the poster child for familial AML.
Rio-Machin A; Fitzgibbon J
Blood; 2022 Aug; 140(7):667-669. PubMed ID: 35980681
[No Abstract] [Full Text] [Related]
7. Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia.
Cardoso SR; Ryan G; Walne AJ; Ellison A; Lowe R; Tummala H; Rio-Machin A; Collopy L; Al Seraihi A; Wallis Y; Page P; Akiki S; Fitzgibbon J; Vulliamy T; Dokal I
Leukemia; 2016 Oct; 30(10):2083-2086. PubMed ID: 27133828
[No Abstract] [Full Text] [Related]
8. DDX41: the poster child for familial MDS/AML grows up.
Truong P; Pimanda JE
Blood; 2023 Feb; 141(5):447-449. PubMed ID: 36729548
[No Abstract] [Full Text] [Related]
9. A novel bi-alleleic DDX41 mutations in B-cell lymphoblastic leukemia: case report.
Shin WY; Yoon SY; Park R; Kim JA; Song HH; Bang HI; Won JH; Kim J
BMC Med Genomics; 2022 Mar; 15(1):46. PubMed ID: 35246110
[TBL] [Abstract][Full Text] [Related]
10. Germline DDX41 mutations define a significant entity within adult MDS/AML patients.
Sébert M; Passet M; Raimbault A; Rahmé R; Raffoux E; Sicre de Fontbrune F; Cerrano M; Quentin S; Vasquez N; Da Costa M; Boissel N; Dombret H; Peffault de Latour R; Socié G; Itzykson R; Fenaux P; Soulier J; Adès L; Clappier E
Blood; 2019 Oct; 134(17):1441-1444. PubMed ID: 31484648
[TBL] [Abstract][Full Text] [Related]
11. Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
Al-Kali A; Nanaa A; Viswanatha D; He R; Nguyen P; Jevremovic D; Foran JM; Yi CA; Greipp PT; Gangat N; Patnaik M; Tefferi A; Litzow MR; Mangaonkar AA; Shah MV; Badar T; Alkhateeb HB
Blood Cancer J; 2023 Apr; 13(1):49. PubMed ID: 37032414
[No Abstract] [Full Text] [Related]
12. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.
Polprasert C; Schulze I; Sekeres MA; Makishima H; Przychodzen B; Hosono N; Singh J; Padgett RA; Gu X; Phillips JG; Clemente M; Parker Y; Lindner D; Dienes B; Jankowsky E; Saunthararajah Y; Du Y; Oakley K; Nguyen N; Mukherjee S; Pabst C; Godley LA; Churpek JE; Pollyea DA; Krug U; Berdel WE; Klein HU; Dugas M; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Yoshida K; Ogawa S; Müller-Tidow C; Maciejewski JP
Cancer Cell; 2015 May; 27(5):658-70. PubMed ID: 25920683
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia.
Baranwal A; Nanaa A; Viswanatha D; He R; Foran J; Badar T; Hogan WJ; Litzow MR; Shah MV; Patnaik MM; Al-Kali A; Alkhateeb HB
Bone Marrow Transplant; 2022 Nov; 57(11):1716-1718. PubMed ID: 35987913
[No Abstract] [Full Text] [Related]
14. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
Makishima H; Saiki R; Nannya Y; Korotev S; Gurnari C; Takeda J; Momozawa Y; Best S; Krishnamurthy P; Yoshizato T; Atsuta Y; Shiozawa Y; Iijima-Yamashita Y; Yoshida K; Shiraishi Y; Nagata Y; Kakiuchi N; Onizuka M; Chiba K; Tanaka H; Kon A; Ochi Y; Nakagawa MM; Okuda R; Mori T; Yoda A; Itonaga H; Miyazaki Y; Sanada M; Ishikawa T; Chiba S; Tsurumi H; Kasahara S; Müller-Tidow C; Takaori-Kondo A; Ohyashiki K; Kiguchi T; Matsuda F; Jansen JH; Polprasert C; Blombery P; Kamatani Y; Miyano S; Malcovati L; Haferlach T; Kubo M; Cazzola M; Kulasekararaj AG; Godley LA; Maciejewski JP; Ogawa S
Blood; 2023 Feb; 141(5):534-549. PubMed ID: 36322930
[TBL] [Abstract][Full Text] [Related]
15. The emerging roles of the DDX41 protein in immunity and diseases.
Jiang Y; Zhu Y; Liu ZJ; Ouyang S
Protein Cell; 2017 Feb; 8(2):83-89. PubMed ID: 27502187
[TBL] [Abstract][Full Text] [Related]
16. Clinical and mechanistic insights into the roles of DDX41 in haematological malignancies.
Weinreb JT; Bowman TV
FEBS Lett; 2022 Nov; 596(21):2736-2745. PubMed ID: 36036093
[TBL] [Abstract][Full Text] [Related]
17. Functionally relevant RNA helicase mutations in familial and sporadic myeloid malignancies.
Antony-Debré I; Steidl U
Cancer Cell; 2015 May; 27(5):609-11. PubMed ID: 25965566
[TBL] [Abstract][Full Text] [Related]
18. VEXAS syndrome in a patient with DDX41 germline predisposition syndrome.
Kusne Y; Lasho T; Finke C; Patnaik MM; Badar T
Leuk Res; 2024 Jan; 136():107432. PubMed ID: 38159331
[No Abstract] [Full Text] [Related]
19. The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
Li P; Brown S; Williams M; White T; Xie W; Cui W; Peker D; Lei L; Kunder CA; Wang HY; Murray SS; Vagher J; Kovacsovics T; Patel JL
Blood; 2022 Aug; 140(7):716-755. PubMed ID: 35671390
[TBL] [Abstract][Full Text] [Related]
20. Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation.
Abou Dalle I; Kantarjian H; Bannon SA; Kanagal-Shamanna R; Routbort M; Patel KP; Hu S; Bhalla K; Garcia-Manero G; DiNardo CD
Am J Hematol; 2020 Feb; 95(2):227-229. PubMed ID: 31400013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
